Predictive markers in bladder cancer: do we have molecular markers ready for clinical use?
about
Urinary cell microRNA-based prognostic classifier for non-muscle invasive bladder cancerHuman epidermal growth factor receptor 2 expression is more important than Bacillus Calmette Guerin treatment in predicting the outcome of T1G3 bladder cancer.Novel robust biomarkers for human bladder cancer based on activation of intracellular signaling pathways.Detection of multiple mutations in urinary exfoliated cells from male bladder cancer patients at diagnosis and during follow-upDeveloping proteomic biomarkers for bladder cancer: towards clinical application.MicroRNA expression profiling in bladder cancer: the challenge of next-generation sequencing in tissues and biofluids.Key signaling pathways in the muscle-invasive bladder carcinoma: Clinical markers for disease modeling and optimized treatment.Did the reporting of prognostic studies of tumour markers improve since the introduction of REMARK guideline? A comparison of reporting in published articles.MicroRNAs with prognostic significance in bladder cancer: a systematic review and meta-analysis.H2AX phosphorylation level in peripheral blood mononuclear cells as an event-free survival predictor for bladder cancer.Asymptomatic solitary bladder plasmocytoma: A case report and literature review.Nested quantitative PCR approach for urinary cell-free EZH2 mRNA and its potential clinical application in bladder cancer.The association of pretreatment serum albumin with outcomes in bladder cancer: a meta-analysis.The complex relationship between upper urinary tract and bladder cancer: clinical and predictive issues.microRNA profiles in urine by next-generation sequencing can stratify bladder cancer subtypes.
P2860
Q33566895-0C7B9D64-1495-4D68-8918-7AC311653EAAQ33648897-801C873D-6D43-4D0C-A05C-47028F291036Q34619203-710FA809-B033-4503-8B88-61277BB3CB65Q37687183-76131708-8A76-45A2-9B69-9847E9330598Q38511509-EAED7981-94A3-4A74-8A6D-431942BF8D59Q38613417-66BD8737-BAC4-4E95-9DD3-1C39F0F77E6DQ38627721-5690CA0C-DE36-44E6-9C5E-43EA908F67F0Q38671095-56734301-B234-49D1-9B24-00B5C08732ABQ39440371-2A31B818-7AB5-40A2-9D6A-CCFF72BD3A60Q39579247-4B8D46FD-F774-4B98-8436-CCF07B8BEADFQ47547109-C992F545-34D7-429F-AC9E-0BC98A25DEE2Q48200477-5ADAC794-4B32-4F09-985C-BA24F08DE23BQ55284422-AAE574A3-23A3-4D3F-93F7-5500D41537FAQ55344035-9354B107-3AD1-4CA1-9EBD-8E3D6307548BQ55385354-94628A55-8026-4909-98CF-3FA15CF68B4C
P2860
Predictive markers in bladder cancer: do we have molecular markers ready for clinical use?
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Predictive markers in bladder ...... arkers ready for clinical use?
@en
type
label
Predictive markers in bladder ...... arkers ready for clinical use?
@en
prefLabel
Predictive markers in bladder ...... arkers ready for clinical use?
@en
P2093
P2860
P1476
Predictive markers in bladder ...... arkers ready for clinical use?
@en
P2093
Giuseppe Carrieri
Luigi Cormio
Pantaleo Bufo
P2860
P304
P356
10.3109/10408363.2014.930412
P577
2014-07-18T00:00:00Z